SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000903423-18-000546
Filing Date
2018-10-10
Accepted
2018-10-10 19:53:02
Documents
1
Period of Report
2018-10-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT allogene.html 3  
1 OWNERSHIP DOCUMENT allogene.xml 3 8293
  Complete submission text file 0000903423-18-000546.txt   10592
Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
BONDERMAN DAVID (Reporting) CIK: 0000860866 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38693 | Film No.: 181117121

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
COULTER JAMES G (Reporting) CIK: 0001099776 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38693 | Film No.: 181117122

Mailing Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102
Business Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102 817-871-4000
TPG Group Holdings (SBS) Advisors, Inc. (Reporting) CIK: 0001495741 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-38693 | Film No.: 181117120

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Issuer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)